StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ACES.JK$348.00+0.00%
Fair $348.00+0.0%

ACES.JK

PT Aspirasi Hidup Indonesia Tbk

Consumer Cyclical / Specialty RetailJakarta

$348.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $348.00Fund rank 37/100 · Data gapFallback financials|
SA 53/C
F-Score: 1/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.2T · quality 76.7/100

Data gap 37/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 75/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

53/100

C

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · ACES.JKLocal privado en este navegador · PT Aspirasi Hidup Indonesia Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$5.96T

P/E

8.7x

↓

EV/EBITDA

3.2x

↓

ROE

10.3%

↑

Gross Margin

47.6%

↑

Debt/Equity

0.16

↓
52-Week Range$348
$340$610

TradingView lightweight chart

ACES.JK price, volumen y niveles de valoración

Último $348.00Periodo +255.1%
Fair value: $348.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+8.5%

FCF CAGR

+41.9%

FCF margin

16.9%

FCF / Net income

2.18x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $8.64T · net income $668.73B · FCF $1.46T

2022-FY → 2025-FY

Gross margin

47.6%-0.7% pts

Operating margin

7.2%-3.8% pts

Net margin

7.7%-2.1% pts

FCF margin

16.9%+9.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$8638.65B$8638.65B$8582.51B$7620.15B$6762.80B
Net Income$668.73B$668.73B$892.04B$770.40B$664.34B
EBITDA$1458.19B$1458.19B$1669.10B$1512.61B$1342.39B
EPS——51.9744.6338.83
Gross Margin47.6%47.6%48.7%48.7%48.3%
Operating Margin7.2%7.2%11.9%11.4%11.0%
Net Margin7.7%7.7%10.4%10.1%9.8%
Balance Sheet
Debt/Equity0.160.160.140.140.12
Current Ratio9.369.36———
Cash Flow
Free Cash Flow$1459.60B$1459.60B$603.09B$1174.68B$511.35B
Returns
ROE10.3%10.3%13.8%12.5%11.3%
Valuation
P/E8.658.6514.5316.8012.62
EV/EBITDA3.243.247.197.535.14
P/B0.910.912.002.091.42
Growth & Yield
Revenue Growth0.7%0.7%12.6%12.7%—
EPS Growth——16.4%14.9%—
Dividend Yield9.7%9.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -25.2%

Total return

-25.2%

Start / end P/E

n/dx → n/dx

EPS bridge

51.97 → n/d

Residual

-35.0%

EPS growthn/d
Multiple reratingn/d
Dividend+9.7%
Residual / FX / buybacks / cross-term-35.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.